【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by disease type
• Rheumatoid arthritis
• Osteoarthritis
• Osteoporosis
• Psoriatic arthritis
• Ankylosing spondylitis
• Fibromyalgia
PART 08: Global rheumatoid arthritis drugs market
• Market overview
PART 09: Global osteoarthritis drugs market
• Market overview
PART 10: Global osteoporosis drugs market
• Market overview
PART 11: Global ankylosing spondylitis drugs market
• Market overview
PART 12: Global psoriatic arthritis drugs market
• Market overview
PART 13: Global fibromyalgia drugs market
• Market overview
PART 14: Market segmentation by type of molecule
• Biologics
• Small molecules
PART 15: Market segmentation by route of administration
• Parenteral
• Topical
• Oral
PART 16: Geographical segmentation
• Global musculoskeletal disorder therapeutics market by geography 2015-2020
• Musculoskeletal disorders therapeutics market in Americas
• Musculoskeletal disorders therapeutics market in EMEA
• Musculoskeletal disorders therapeutics market in APAC
PART 17: Market drivers
• High growth potential of mAbs
• Unmet needs of therapeutics
• Tentative approval of advanced drugs
• Technological advancements in medical imaging
• Combination therapies
PART 18: Impact of drivers
PART 19: Market challenges
• Non-adherence to treatment regimen
• Growing preference toward surgeries
• Multiple patent expiries
PART 20: Impact of drivers and challenges
PART 21: Market trends
• Focus on regenerative medicines
• Ongoing active clinical trials for biosimilars
• Growing focus toward abuse-resistant novel drugs
PART 22: Vendor landscape
• Competitive scenario
PART 23: Key vendor analysis
• AbbVie
• Johnson & Johnson
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Eli Lilly
• Other prominent vendors
PART 24: Appendix
• List of abbreviations
PART 25: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments for musculoskeletal disorder therapeutics
Exhibit 03: Impact of biologics on various sectors
Exhibit 04: Pipeline portfolio: Global rheumatoid arthritis drugs market
Exhibit 05: Pipeline portfolio: Global osteoarthritis drugs market
Exhibit 06: Pipeline portfolio: Global osteoporosis drugs market
Exhibit 07: Pipeline portfolio: Global psoriatic arthritis drugs market
Exhibit 08: Pipeline portfolio: Global fibromyalgia drugs market
Exhibit 09: Pipeline portfolio: Global ankylosing spondylitis drugs market
Exhibit 10: Global musculoskeletal disorder therapeutics market 2015-2020 ($ billions)
Exhibit 11: Patient assistance programs offered by companies
Exhibit 12: CAM therapies for rheumatoid arthritis
Exhibit 13: Five forces analysis
Exhibit 14: Segmentation of global musculoskeletal disorder therapeutics market
Exhibit 15: Segmentation of global musculoskeletal disorder therapeutics market by revenue 2015
Exhibit 16: Opportunities in rheumatoid arthritis drugs industry
Exhibit 17: Global rheumatoid arthritis drugs market 2015-2020 ($ billions)
Exhibit 18: Unmet medical needs with current osteoarthritis treatments
Exhibit 19: Global osteoarthritis drugs market 2015-2020 ($ billions)
Exhibit 20: Global osteoporosis drugs market 2015-2020 ($ billions)
Exhibit 21: Global ankylosing spondylitis drugs market 2015-2020 ($ billions)
Exhibit 22: Global psoriatic arthritis drugs market 2015-2020 ($ billions)
Exhibit 23: Global fibromyalgia drugs market 2015-2020 ($ billions)
Exhibit 24: Segmentation of global musculoskeletal disorder therapeutics market by type of molecules 2015
Exhibit 25: Segmentation of global musculoskeletal disorder therapeutics market by ROA 2015
Exhibit 26: Global musculoskeletal disorder therapeutics market by geography 2015-2020
Exhibit 27: Global musculoskeletal disorder therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 28: Global share of musculoskeletal disorders therapeutics market by geography 2015
Exhibit 29: Global musculoskeletal disorder therapeutics market: Country analysis based on revenue and growth rate
Exhibit 30: Musculoskeletal disorders therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 31: Musculoskeletal disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 32: Musculoskeletal disorders therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 33: Few of the late-stage mAbs under development for various musculoskeletal disorders
Exhibit 34: Impact of drivers
Exhibit 35: Approval and patent expiries of top selling biologics
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Key vendors ranking 2015
Exhibit 38: Geographical presence of key vendors
Exhibit 39: Competitive scenario of global musculoskeletal disorder therapeutics market vendors 2015-2020
Exhibit 40: AbbVie: YoY revenue and growth rate of Humira 2013-2015 ($ billions)
Exhibit 41: AbbVie: Geographical segmentation of Humira 2015
Exhibit 42: AbbVie: Metrics analysis
Exhibit 43: Key products in musculoskeletal disorders market with 2015 revenues
Exhibit 44: Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 45: Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 46: Johnson & Johnson: YoY revenue and growth rate of Stelara 2013-2015 ($ billions)
Exhibit 47: Johnson & Johnson: Metrics analysis
Exhibit 48: Amgen: YoY revenue and growth rate of Enbrel (US and Canada) 2013-2015 ($ billions)
Exhibit 49: Amgen: YoY revenue and growth rate of Prolia 2013-2015 ($ billions)
Exhibit 50: Amgen: Geographical segmentation of Prolia 2015
Exhibit 51: Amgen: Metrics analysis
Exhibit 52: Key products in musculoskeletal disorders market with 2015 revenues
Exhibit 53: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 54: Pfizer: YoY revenue and growth rate of Enbrel (outside US and Canada) 2013-2015 ($ billions)
Exhibit 55: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
Exhibit 56: Pfizer: YoY revenue and growth rate of Xeljanz 2013-2015 ($ millions)
Exhibit 57: Pfizer: Metrics analysis
Exhibit 58: F. Hoffmann-La Roche: YoY revenue and growth rate of MabThera/Rituxan 2013-2015 ($ billions)
Exhibit 59: F. Hoffmann-La Roche: Geographical segmentation of MabThera/Rituxan by revenue 2015
Exhibit 60: F. Hoffmann-La Roche: YoY revenue and growth rate of Actemra/RoActemra 2013-2015 ($ billions)
Exhibit 61: F. Hoffmann-La Roche: Geographical segmentation of Actemra/RoActemra by revenue 2015
Exhibit 62: F. Hoffmann-La Roche: Metrics analysis
Exhibit 63: Eli Lilly: YoY revenue and growth rate of Cymbalta 2013-2015 ($ billions)
Exhibit 64: Eli Lilly: YoY revenue and growth rate of Evista 2013-2015 ($ billions)
Exhibit 65: Eli Lilly: Geographical segmentation of Evista 2015
Exhibit 66: Eli Lilly: YoY revenue and growth rate of Forteo 2013-2015 ($ billions)
Exhibit 67: Eli Lilly: Geographical segmentation of Forteo 2015
Exhibit 68: Eli Lilly: Metrics analysis
【レポート販売概要】
■ タイトル：筋骨格障害治療薬の世界市場：リウマチ性関節炎、骨関節炎、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症■ 英文：Global Musculoskeletal Disorders Therapeutics Market 2016-2020
■ 発行日：2016年8月31日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10170
■ 調査対象地域：グローバル
- 熱収縮チューブの世界市場予測（～2024年）“The global heat-shrink tubing market is projected to grow at a CAGR of 5.3% from 2019 to 2024” The global heat-shrink tubing market is projected to reach USD 2.3 billion by 2024 from an estimated USD 1.8 billion in 2019, at a CAGR of 5.3% during the forecast period. This growth can be attributed to factors such as government initiatives to expand and upgrade T&D systems and increasing power gener …
- ジオメンブレンの世界市場2015-2019About Geomembranes Geomembranes are synthetic membrane liners used in geotechnical engineering to contain or control the flow of fluids or vapors. The two common processes used to manufacture geomembranes are calendering and extrusion; the raw materials used are polyethylene, bitumen composites, or geotextiles in combination with polymer sprays, colorants, asphalt, or elastomers. HDPE, LDPE, PVC, …
- 自動車トランスミッションの世界市場：手動変速機(MT)、自動変速機(AT)、AMT、無段変速機(CVT)A transmission system is one of the vital components of an automobile that propagates power from the engine to the wheels in order to set the vehicle in motion. This system utilizes the clutch and gears to provide speed and torque conversions from crank shaft to wheels. Transmission systems have been evolving from manual to automatic or from 5 speed gears to even 16 speed gears. Changing consumer …
- 1,3-プロパンジオールの世界市場1,3-Propanediol is an organic compound manufactured through fermentation of biobased feedstock such as corn sugar, crude glycerol etc. Conventionally, The global 1,3-Propanediol market is estimated to reach $621.2 million by 2021 growing at a CAGR of 10.4% from 2014. This report on 1,3-Propanediol market covers all major regions such as Asia-Pacific (APAC), Americas, and Europe, Middle East & Afri …
- 品質管理ソフトウェアの世界市場展望2017-20276According to Stratistics MRC, the Global Quality Management Software Market is accounted for $6.65 billion in 2017 and is expected to reach $17.85 billion by 2026 growing at a CAGR of 11.6% during the forecast period. The market is propelling due to the rising technological advancements and telecom & regulatory norms along with increasing compliance demands. However, high deployment and maintenanc …
- 分散剤の世界市場2016-2020About Dispersing Agents Dispersing agents are surface-active substances that ease the dispersion of an immiscible chemical in a solvent. These are also called dispersants or plasticizers. Dispersants decrease the surface tension, preventing settling or coagulation of particles and ensuring uniform consistency in blends and particles. Adding these agents to a colloid prevents clustering and enhance …
- 世界の限外ろ過市場：用途別、地域別Global Ultrafiltration Market: About this market Technavio’s ultrafiltration market analysis considers sales from municipal treatment and industrial treatment applications. Our study also finds the sales of ultrafiltration in APAC, Europe, MEA, North America, and South America. In 2019, the municipal treatment segment had a significant market share, and this trend is expected to continue over the …
- GEUDER AG：市場シェア分析GEUDER AG Market Share Analysis Summary GlobalData’s new report, “GEUDER AG Market Share Analysis” provides in-depth information on GEUDER AG’s market position in the vitreo retinal surgery devices market. The report also provides data and information on the overall competitive landscape within the vitreo retinal surgery devices market. The report is supplemented with global corporate-level profil …
- デンドリマーの世界市場2010-2025Dendrimers are widely investigated and utilized in biomedical applications, as they have multiple surface functional groups that can be used to target or label the dendrimer for imaging and drug delivery applications. They have found application in transdermal drug delivery systems and show potential in gene delivery and for enhancing the oral bioavailability of problematic drugs. Their are a numb …
- Forest Oil Corporation：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Forest Oil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Forest Oil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 黒色腫治療薬の世界市場予測および分析PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023 Summary Melanoma is the deadliest and most aggressive form of skin cancer. The major treatments for melanoma are categorized into immunotherapies and BRAF mutation-targeted therapies. GlobalData estimates the 2013 sales for melanoma at approximately $1.34 billion across the 8MM covered in this report. The market will increase …
- インスタントコーヒーの世界市場2016-2020：噴霧乾燥インスタントコーヒー、凍結乾燥インスタントコーヒーAbout Instant Coffee Instant coffee is prepared by vaporizing brewed coffee beans. It is available in the form of powder and differs from freshly brewed coffee in terms of flavor and aroma. The main advantage of instant coffee is the convenience in preparing it. Also, it requires less equipment for preparation. Although fresh coffee dominates the overall coffee market, instant coffee continues to …
- 穴掘り機の世界市場2016-2020About Drilling Machines Drilling is cutting method where a drill bit is used to make a circular cross-section in any solid material. A drill bit is a multi-point rotary cutting tool. It is attached to the machine that makes it rotate at speeds ranging from hundreds to thousands of revolutions per minute. This, when pressed against the workpiece, creates the desired hole by cutting off chips from t …
- ギ酸メチルの世界市場Methyl Formate (CAS 107-31-3) Market Research Report 2013 presents comprehensive data on methyl formate markets globally and regionally (Europe, Asia, North America etc.) The Methyl Formate (CAS 107-31-3) Market Research Report 2013 includes methyl formate description, covers its application areas and related patterns. It overviews methyl formate market, names methyl formate producers and indicate …
- WPX Energy, Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）WPX Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary WPX Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
